Every year, the flu evolves, and so must our vaccines. But here's where it gets intriguing: the 2026 seasonal influenza vaccines are undergoing significant changes, and some of these updates might surprise you. Let’s dive into what’s new, why it matters, and what it means for you and your family.
The Flu Vaccine: A Yearly Update
You might wonder why you need a flu shot every year. The answer lies in the flu virus itself. Influenza is a master of disguise, constantly mutating into new strains. To keep up, the vaccines must be updated annually. This year, the Australian Influenza Vaccine Committee (AIVC) has been hard at work, analyzing the latest data on flu strains circulating in Australia and the southern hemisphere. They’ve reviewed everything from epidemiology to genetic data, and even the effectiveness of the 2024-2025 vaccines. Based on their findings and recommendations from the World Health Organization (WHO), the 2026 vaccines include two new strains: an A(H1N1)-like and an A(H3N2)-like virus. But here’s where it gets controversial: the WHO has advised dropping the B/Yamagata lineage from seasonal vaccines, as it hasn’t been detected in circulation for years. This shift has sparked debates among experts, with some questioning whether we’re moving too quickly. What do you think? Is this a prudent decision or a risky move?
What’s in the 2026 Vaccines?
The 2026 vaccines are trivalent, meaning they protect against three strains of the flu. Here’s the breakdown:
Egg-based trivalent vaccines contain:
- A/Missouri/11/2025 (H1N1)pdm09-like virus
- A/Singapore/GP20238/2024 (H3N2)-like virus
- B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
Cell-based trivalent vaccines include:
See AlsoLibya Eliminates Trachoma! WHO Validates Historic Public Health Victory 🇱🇾UNSW Sydney's Cardiovascular Research Excellence: Awards and InnovationsCollagen Supplements: Skin Benefits vs. No Performance Gains | New Study RevealsSleep for Your Heart: How Insufficient Sleep Raises AF Risk in Working Adults- A/Missouri/11/2025 (H1N1)pdm09-like virus
- A/Sydney/1359/2024 (H3N2)-like virus
- B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
And this is the part most people miss: the transition to trivalent vaccines means the B/Yamagata lineage is no longer included. While this simplifies the vaccine, it also raises questions about whether we’re leaving a gap in protection. What’s your take on this change?
Flu and COVID-19 Vaccines: Can You Get Both at Once?
Good news: you can receive your flu and COVID-19 vaccines on the same day. Studies have shown that co-administration is safe and effective, ensuring you’re protected against both viruses without any additional risk. If you’re unsure about timing or eligibility, consult your healthcare provider or visit the Australian Technical Advisory Group on Immunisation (ATAGI) website for detailed guidance.
2026 Vaccine Options in Australia
This year, Australia offers seven influenza vaccines, each tailored to specific age groups:
| Sponsor | Tradename | Age Group |
|------------------|-----------------|------------------------------------|
| AstraZeneca | FluMist# | 2 years to less than 18 years |
| Sanofi-Aventis | Fluzone | 6 months and over |
| | Fluzone HD | 60 years and over |
| | Vaxigrip | 6 months and over |
| Seqirus | Fluad | 50 years and over |
| | Flucelvax | 6 months and over |
| Viatris | Influvac | 6 months and over |
FluMist, a new addition in 2026, is a needle-free nasal spray ideal for children and adolescents. It’s available on the private market and in some states under sponsored programs. For instance, New South Wales, Queensland, and South Australia offer FluMist to children aged 2 to 5, while Western Australia extends it to those up to 11 years old.
Most vaccines are available free of charge under the National Immunisation Program (NIP), with exceptions like Fluzone and Influvac, which are private market only. Flucelvax, produced using mammalian cell culture, is available both privately and through the NIP.
Vaccines for Different Age Groups
- Children (6 months to under 5 years): Free annual vaccines under the NIP. Options include Flucelvax, Fluzone, Influvac, and Vaxigrip. FluMist is also available for children aged 2 to under 18.
- Under 65s: Flucelvax, Fluzone, Influvac, and Vaxigrip are available. Flucelvax and Vaxigrip are provided under the NIP for at-risk groups, including Aboriginal and Torres Strait Islander people, pregnant women, and those with specific medical conditions.
- Over 65s: Six vaccines are registered, including Fluad (adjuvanted for better immune response in those over 50) and Fluzone HD (higher antigen content for those over 60). All are free under the NIP.
What’s Actually in the Flu Vaccine?
If you’re curious about the ingredients, you can find detailed information on the product label, Product Information (PI), or Consumer Medicine Information (CMI) leaflets. These documents list all components, including whether the vaccine contains egg proteins or adjuvants. For example, Fluad includes an adjuvant to boost immunity in older adults, while Flucelvax is egg-free, making it suitable for those with egg allergies.
Here’s a surprising fact: formaldehyde is used in the early stages of some vaccine production to inactivate the virus. However, it’s removed later, and final products are tested to ensure levels are undetectable. All 2026 vaccines are latex-free, though cross-contamination during manufacturing can’t be entirely ruled out. If you have a severe latex allergy, consult your doctor.
Stay Informed and Report Adverse Events
The Department of Health, Disability and Aging, along with state and territory health authorities, will closely monitor adverse event reports during the 2026 vaccination program. If you experience any side effects, report them to your healthcare provider or through the TGA’s reporting system. Your feedback helps ensure the safety and effectiveness of these vaccines.
Final Thoughts
The 2026 flu vaccines are a testament to ongoing scientific advancements in combating influenza. However, the shift to trivalent vaccines and the exclusion of the B/Yamagata lineage have sparked debates. What’s your opinion? Are these changes a step forward or a potential oversight? Share your thoughts in the comments below, and let’s keep the conversation going. Stay informed, stay protected, and remember—getting vaccinated isn’t just about you; it’s about protecting your community too.
For more details, visit the ATAGI Influenza Statement or NPS MedicineWise for consumer-friendly resources. And if you’re ever in doubt, your healthcare provider is your best source of advice. Stay healthy!
